Российский журнал гастроэнтерологии, гепатологии, колопроктологии (Jun 2021)

Practical Recommendations of Scientific Society for the Study of Human Microbiome and the Russian Gastroenterological Association on Use of Probiotics, Prebiotics, Synbiotics and Functional Foods in Treatment and Prevention of Gastroenterological Diseases in Children and Adults

  • V. T. Ivashkin,
  • I. V. Maev,
  • D. I. Abdulganieva,
  • S. A. Alekseenko,
  • A. V. Gorelov,
  • I. N. Zakharova,
  • O. Yu. Zolnikova,
  • N. Yu. Ivashkina,
  • N. V. Korochanskaya,
  • S. N. Mammayev,
  • E. A. Poluektova,
  • A. S. Trukhmanov,
  • D. V. Usenko,
  • Yu. P. Uspensky,
  • V. V. Tsukanov,
  • O. S. Shifrin,
  • I. V. Berezhnaya,
  • K. V. Ivashkin,
  • T. L. Lapina,
  • R. V. Maslennikov,
  • S. V. Nikolaeva,
  • N. G. Sugyan,
  • A. I. Ulyanin

DOI
https://doi.org/10.22416/1382-4376-2021-31-2-65-91
Journal volume & issue
Vol. 31, no. 2
pp. 65 – 91

Abstract

Read online

Aim. The practical guidelines are intended for primary care physicians, general practitioners, paediatricians, gastroenterologists and general internists to advance the treatment and prevention of gastroenterological diseases in adults and children in therapies with probiotics, prebiotics, synbiotics and their enriched functional foods.Key points. Probiotics are live microorganisms that sustain health of the host when supplied in adequate amounts. Prebiotics include human-indigestible but accessible to gut microbiota substances expediting specific changes in the composition and/or activity of gastrointestinal microbiota that favour the host health. The mechanism of probiotic action comprises the quorum resistance maintenance, nutrient substrate metabolism and end metabolite recycling, macroorganism-sustaining substrate production, as well as the mediation of local and adaptive immune responses.The Russian Federation regulates market differently for biologically active food additives (BAFA), medicinal products (drugs) and functional food products (FFP). We overview the probiotic strains regulated in Russia as BAFAs, drugs and FFPs and provide recommendations on the use of these strains in treatment and prevention of gastroenterological diseases in children and adults.Conclusion. The clinical efficacy of probiotics, prebiotics, synbiotics and fortified functional foods depends on the prebiotic and strain properties and is verified in appropriate comparative clinical trials. Not all probiotics registered in Russia as BAFAs, drugs and FFPs have a strain identity, which provides no warranty of the clinical effect expected. The FFP legislation demands improved regulation mechanisms and control for therapeutic efficacy.

Keywords